Precision medicine

Luxembourg’s new molecular diagnostics program aims to establish the value of such analyses as a part of routine cancer care

To harness liquid biopsy’s many advantages, it’s vital to ensure appropriate testing – and cfDNA synthetic plasma reference standards can help

The spatial arrangement of immune cells could predict whether aggressive chemotherapy is the best option for patients with early-stage lung cancer

An electronic gas-sensing capsule may increase diagnostic and monitoring accuracy in disorders of the digestive tract

Markers such as DNA methylation, analyzed by liquid biopsy, may improve on ovarian cancer testing options like gold standard CA125

A collaboration between industry, academia, and the clinic could lead to more efficient, more personalized cancer diagnosis and treatment

New biomarker sensing technology can detect miniscule concentrations of molecules in the blood to assist with patient monitoring

Epigenetics may combine with liquid biopsy to offer an effective way of detecting early-stage cancers and recurrences

With antimicrobial resistance an ever-increasing threat to modern medicine, a new breakthrough may rapidly identify drug-resistant microbe strains to ensure effective treatment

When seeking the greatest benefit from liquid biopsy, droplet digital PCR can help by offering speed, sensitivity, and absolute quantitation